Prostaglandin and leukotriene synthesis inhibition — Drug Target

All drugs that target Prostaglandin and leukotriene synthesis inhibition — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

5-aminosalicylic acid (5-ASA) agent

Phase 3 pipeline (1)

• Granulated mesalamine · Bausch Health Americas, Inc. · 5-aminosalicylic acid (5-ASA) agent · Gastroenterology / Immunology
  Mesalamine is an anti-inflammatory agent that acts locally in the colon to reduce inflammation by inhibiting prostaglandin and leukotriene production.